Yingying Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yingying Zhang has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Tianhao Bao
Department of Research and Education, The Affiliated Mental Health Center of Kunming Medical University, Kunming, Yunnan Province, China
2 shared publications - Haoran Xing
Affiliated Mental Health Centre of Kunming Medical University Kunming Yunnan China
1 shared publication Hong Ye
Mental Health Centre of Kunming Medical University Kunming Yunnan 650225 P. R. China
1 shared publication- Hong Ye
Department of Pathology , 71240 Kunming Medical University , Kunming , 650500 , People’s Republic of China
1 shared publication - Jie Wu
Department of Science and Education , 71240 Kunming Medical University Affiliated Mental Health Center , Yunnan Province Mental Hospital, Kunming , 650224 , People’s Republic of China
1 shared publication Li Ma
Mental Health Centre of Kunming Medical University Kunming Yunnan 650225 P. R. China
1 shared publication
Latest Publications
- 24 January 2025
- Published by Walter de Gruyter GmbH in Reviews in the Neurosciences
- Vol. 36 (5) , 545-576
Advances in repetitive transcranial magnetic stimulation in the treatment of treatment-resistant depression: a comprehensive review
Major depressive disorder is a common mental disorder, and a significant number of patients exhibit poor response to conventional antidepressant treatments, known as treatment-resistant depression (TRD). However, the definition of TRD globally remains unclear, impeding clinical research, treatment development, outcome implementation, and policy-making. A wealth of research confirms that rTMS demonstrates promising efficacy in TRD. This paper elucidates the definition of TRD, summarizes potential targets of rTMS for treating TRD, comprehensively elaborates on the unique mechanisms, efficacy, and side effects of rTMS in treating TRD, and outlines considerations for special populations receiving rTMS treatment for TRD as well as other treatment modalities for TRD. Through these studies, we aim to provide more scientifically grounded recommendations for patients undergoing rTMS treatment for TRD.
- 24 January 2025
- Published by Walter de Gruyter GmbH in Reviews in the Neurosciences
- Vol. 36 (5) , 545-576
Advances in repetitive transcranial magnetic stimulation in the treatment of treatment-resistant depression: a comprehensive review
Major depressive disorder is a common mental disorder, and a significant number of patients exhibit poor response to conventional antidepressant treatments, known as treatment-resistant depression (TRD). However, the definition of TRD globally remains unclear, impeding clinical research, treatment development, outcome implementation, and policy-making. A wealth of research confirms that rTMS demonstrates promising efficacy in TRD. This paper elucidates the definition of TRD, summarizes potential targets of rTMS for treating TRD, comprehensively elaborates on the unique mechanisms, efficacy, and side effects of rTMS in treating TRD, and outlines considerations for special populations receiving rTMS treatment for TRD as well as other treatment modalities for TRD. Through these studies, we aim to provide more scientifically grounded recommendations for patients undergoing rTMS treatment for TRD.
- 10 April 2024
- Published by Wiley in Advanced Biology
- Vol. 8 (6) , 2300409
Progress in The Research of Lactate Metabolism Disruption And Astrocyte‐Neuron Lactate Shuttle Impairment in Schizophrenia: A Comprehensive Review
Schizophrenia (SCZ) is a complex neuropsychiatric disorder widely recognized for its impaired bioenergy utilization. The astrocyte‐neuron lactate shuttle (ANLS) plays a critical role in brain energy supply. Recent studies have revealed abnormal lactate metabolism in SCZ, which is associated with mitochondrial dysfunction, tissue hypoxia, gastric acid retention, oxidative stress, neuroinflammation, abnormal brain iron metabolism, cerebral white matter hypermetabolic activity, and genetic susceptibility. Furthermore, astrocytes, neurons, and glutamate abnormalities are prevalent in SCZ with abnormal lactate metabolism, which are essential components for maintaining ANLS in the brain. Therefore, an in‐depth study of the pathophysiological mechanisms of ANLS in SCZ with abnormal lactate metabolism will contribute to a better understanding of the pathogenesis of SCZ and provide new ideas and approaches for the diagnosis and treatment of SCZ.
- 10 April 2024
- Published by Wiley in Advanced Biology
- Vol. 8 (6) , 2300409
Progress in The Research of Lactate Metabolism Disruption And Astrocyte‐Neuron Lactate Shuttle Impairment in Schizophrenia: A Comprehensive Review
Schizophrenia (SCZ) is a complex neuropsychiatric disorder widely recognized for its impaired bioenergy utilization. The astrocyte‐neuron lactate shuttle (ANLS) plays a critical role in brain energy supply. Recent studies have revealed abnormal lactate metabolism in SCZ, which is associated with mitochondrial dysfunction, tissue hypoxia, gastric acid retention, oxidative stress, neuroinflammation, abnormal brain iron metabolism, cerebral white matter hypermetabolic activity, and genetic susceptibility. Furthermore, astrocytes, neurons, and glutamate abnormalities are prevalent in SCZ with abnormal lactate metabolism, which are essential components for maintaining ANLS in the brain. Therefore, an in‐depth study of the pathophysiological mechanisms of ANLS in SCZ with abnormal lactate metabolism will contribute to a better understanding of the pathogenesis of SCZ and provide new ideas and approaches for the diagnosis and treatment of SCZ.